These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34982304)

  • 1. CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.
    França TT; Barreiros LA; Salgado RC; Napoleão SMDS; Gomes LN; Ferreira JFS; Prando C; Weber CW; Di Gesu RSW; Montenegro C; Aranda CS; Kuntze G; Staines-Boone AT; Venegas-Montoya E; Becerra JCA; Bezrodnik L; Di Giovanni D; Moreira I; Seminario GA; Raccio ACG; Dorna MB; Rosário-Filho NA; Chong-Neto HJ; de Carvalho E; Grotta MB; Orellana JC; Dominguez MG; Porras O; Sasia L; Salvucci K; Garip E; Leite LFB; Forte WCN; Pinto-Mariz F; Goudouris E; Nuñez MEN; Schelotto M; Ruiz LB; Liberatore DI; Ochs HD; Cabral-Marques O; Condino-Neto A
    J Clin Immunol; 2022 Apr; 42(3):514-526. PubMed ID: 34982304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, genetic and immunological characteristics of 40 Chinese patients with CD40 ligand deficiency.
    Du X; Tang W; Chen X; Zeng T; Wang Y; Chen Z; Xu T; Zhou L; Tang X; An Y; Zhao X
    Scand J Immunol; 2019 Oct; 90(4):e12798. PubMed ID: 31179555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
    Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
    Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency.
    Banday AZ; Nisar R; Patra PK; Kaur A; Sadanand R; Chaudhry C; Bukhari STA; Banday SZ; Bhattarai D; Notarangelo LD
    J Clin Immunol; 2023 Dec; 44(1):17. PubMed ID: 38129705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of collaborative work: the Latin American Society for Immunodeficiencies (LASID) registry model.
    Condino-Neto A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):16-7. PubMed ID: 25546746
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.
    Seyama K; Nonoyama S; Gangsaas I; Hollenbaugh D; Pabst HF; Aruffo A; Ochs HD
    Blood; 1998 Oct; 92(7):2421-34. PubMed ID: 9746782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of paracoccidioidomycosis and other unusual infections in Brazilian patients.
    Cabral-Marques O; Schimke LF; Pereira PV; Falcai A; de Oliveira JB; Hackett MJ; Errante PR; Weber CW; Ferreira JF; Kuntze G; Rosário-Filho NA; Ochs HD; Torgerson TR; Carvalho BT; Condino-Neto A
    J Clin Immunol; 2012 Apr; 32(2):212-20. PubMed ID: 22193914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases.
    Costa-Carvalho B; González-Serrano M; Espinosa-Padilla S; Segundo G
    Expert Rev Clin Immunol; 2017 May; 13(5):483-489. PubMed ID: 27797286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 ligand-deficient T cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability.
    Lobo FM; Scholl PR; Fuleihan RL
    J Immunol; 2002 Feb; 168(3):1473-8. PubMed ID: 11801691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
    Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
    J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives.
    França TT; Barreiros LA; Al-Ramadi BK; Ochs HD; Cabral-Marques O; Condino-Neto A
    Expert Rev Clin Immunol; 2019 May; 15(5):529-540. PubMed ID: 30681380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".
    Kroczek RA; Graf D; Brugnoni D; Giliani S; Korthüer U; Ugazio A; Senger G; Mages HW; Villa A; Notarangelo LD
    Immunol Rev; 1994 Apr; 138():39-59. PubMed ID: 7915248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ.
    Cabral-Marques O; Ramos RN; Schimke LF; Khan TA; Amaral EP; Barbosa Bomfim CC; Junior OR; França TT; Arslanian C; Carola Correia Lima JD; Weber CW; Ferreira JF; Tavares FS; Sun J; D'Imperio Lima MR; Seelaender M; Garcia Calich VL; Marzagão Barbuto JA; Costa-Carvalho BT; Riemekasten G; Seminario G; Bezrodnik L; Notarangelo L; Torgerson TR; Ochs HD; Condino-Neto A
    J Allergy Clin Immunol; 2017 Mar; 139(3):900-912.e7. PubMed ID: 27554817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID).
    Condino-Neto A; Sorensen RU; Gómez Raccio AC; King A; Espinosa-Rosales FJ; Franco JL
    Allergol Immunopathol (Madr); 2015; 43(5):493-7. PubMed ID: 25294607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper IgM Syndrome: a Report from the USIDNET Registry.
    Leven EA; Maffucci P; Ochs HD; Scholl PR; Buckley RH; Fuleihan RL; Geha RS; Cunningham CK; Bonilla FA; Conley ME; Ferdman RM; Hernandez-Trujillo V; Puck JM; Sullivan K; Secord EA; Ramesh M; Cunningham-Rundles C
    J Clin Immunol; 2016 Jul; 36(5):490-501. PubMed ID: 27189378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation.
    van Zelm MC; Bartol SJ; Driessen GJ; Mascart F; Reisli I; Franco JL; Wolska-Kusnierz B; Kanegane H; Boon L; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Jul; 134(1):135-44. PubMed ID: 24418477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
    Bhushan A; Covey LR
    Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives.
    Condino-Neto A; Franco JL; Espinosa-Rosales FJ; Leiva LE; King A; Porras O; Oleastro M; Bezrodnik L; Grumach AS; Costa-Carvalho BT; Sorensen RU
    Allergol Immunopathol (Madr); 2012; 40(3):187-93. PubMed ID: 22445276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.